台湾地区红霉素耐药性链球菌的高发病率。
High incidence of erythromycin-resistant streptococci in Taiwan.
作者信息
Wu J J, Lin K Y, Hsueh P R, Liu J W, Pan H I, Sheu S M
机构信息
Department of Medical Technology, National Cheng Kung University Medical College, Tainan, Taiwan, Republic of China.
出版信息
Antimicrob Agents Chemother. 1997 Apr;41(4):844-6. doi: 10.1128/AAC.41.4.844.
Abstract
The activities of nine antimicrobial agents against 247 isolates of group B, C, F, and G streptococci and viridans group streptococci were studied by the broth microdilution method. Erythromycin resistance was found in 29.7, 41.7, 81.8, 23.5, and 53.3% of the strains of group B, C, F, and G streptococci and viridans group streptococci tested, respectively. Macrolides are not considered an optimal alternative to penicillin in the treatment of streptococcal infections, at least empirically, in Taiwan.
摘要
采用肉汤微量稀释法研究了9种抗菌药物对247株B、C、F和G组链球菌及草绿色链球菌的抗菌活性。在所检测的B、C、F和G组链球菌及草绿色链球菌菌株中，分别有29.7%、41.7%、81.8%、23.5%和53.3%的菌株对红霉素耐药。在台湾，至少根据经验，大环内酯类药物在治疗链球菌感染方面不被认为是青霉素的最佳替代药物。
相似文献
1
High incidence of erythromycin-resistant streptococci in Taiwan.
Antimicrob Agents Chemother. 1997 Apr;41(4):844-6. doi: 10.1128/AAC.41.4.844.
2
Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
Diagn Microbiol Infect Dis. 1997 Dec;29(4):259-63. doi: 10.1016/s0732-8893(97)00159-4.
3
High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.
Antimicrob Agents Chemother. 2001 Nov;45(11):3205-8. doi: 10.1128/AAC.45.11.3205-3208.2001.
4
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.
Antimicrob Agents Chemother. 1996 Sep;40(9):2117-20. doi: 10.1128/AAC.40.9.2117.
5
Antibiotic susceptibility pattern and erythromycin resistance mechanisms in beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates from central Taiwan.
J Microbiol Immunol Infect. 2015 Dec;48(6):613-7. doi: 10.1016/j.jmii.2014.04.003. Epub 2014 May 22.
6
The frequency of resistance to erythromycin in group A streptococci in Ankara.
Eur J Pediatr. 1996 Sep;155(9):780-2. doi: 10.1007/BF02002906.
7
Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.
J Clin Microbiol. 2000 Jul;38(7):2475-9. doi: 10.1128/JCM.38.7.2475-2479.2000.
8
In vitro susceptibility, tolerance and MLS resistance phenotypes of Group C and Group G streptococci isolated in Turkey between 1995 and 2002.
Int J Antimicrob Agents. 2003 Aug;22(2):160-3. doi: 10.1016/s0924-8579(03)00081-5.
9
Viridans group streptococci: a reservoir of resistant bacteria in oral cavities.
Clin Microbiol Infect. 2002 Feb;8(2):65-9. doi: 10.1046/j.1198-743x.2001.00398.x.
10
Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
J Antimicrob Chemother. 2006 Jan;57(1):139-41. doi: 10.1093/jac/dki404. Epub 2005 Nov 16.
引用本文的文献
1
Cross-resistance to lincosamides, streptogramins A, and pleuromutilins due to the lsa(C) gene in Streptococcus agalactiae UCN70.
Antimicrob Agents Chemother. 2011 Apr;55(4):1470-4. doi: 10.1128/AAC.01068-10. Epub 2011 Jan 18.
2
Group B streptococcal disease in nonpregnant patients: emergence of highly resistant strains of serotype Ib in Taiwan in 2006 to 2008.
J Clin Microbiol. 2010 Jul;48(7):2571-4. doi: 10.1128/JCM.00810-10. Epub 2010 May 5.
3
Bacteremia caused by group G Streptococci, taiwan.
Emerg Infect Dis. 2008 May;14(5):837-40. doi: 10.3201/eid1405.070130.
4
Isolation of quinupristin/dalfopristin-resistant Streptococcus agalactiae from asymptomatic Korean women.
J Microbiol. 2008 Feb;46(1):108-11. doi: 10.1007/s12275-007-0217-1.
5
Macrolide resistance trends in beta-hemolytic streptococci in a tertiary Korean hospital.
Yonsei Med J. 2007 Oct 31;48(5):773-8. doi: 10.3349/ymj.2007.48.5.773.
6
The other group G Streptococcus: increased detection of Streptococcus canis ulcer infections in dog owners.
J Clin Microbiol. 2007 Jul;45(7):2327-9. doi: 10.1128/JCM.01765-06. Epub 2007 May 2.
7
Fluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance.
Antimicrob Agents Chemother. 2005 Jun;49(6):2495-7. doi: 10.1128/AAC.49.6.2495-2497.2005.
8
Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2004 Sep;48(9):3462-7. doi: 10.1128/AAC.48.9.3462-3467.2004.
9
Serotypes and genotypes of erythromycin-resistant group B streptococci in Korea.
J Clin Microbiol. 2004 Jul;42(7):3306-8. doi: 10.1128/JCM.42.7.3306-3308.2004.
10
Phenotypic and molecular characterization of erythromycin resistance in four isolates of Streptococcus-like gram-positive cocci causing bacteremia.
J Clin Microbiol. 2004 Jul;42(7):3303-5. doi: 10.1128/JCM.42.7.3303-3305.2004.
本文引用的文献
1
Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.
Antimicrob Agents Chemother. 1996 Apr;40(4):891-4. doi: 10.1128/AAC.40.4.891.
2
Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan.
J Formos Med Assoc. 1996 Jan;95(1):29-36.
3
In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood.
Antimicrob Agents Chemother. 1995 Oct;39(10):2243-7. doi: 10.1128/AAC.39.10.2243.
4
Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan.
Antimicrob Agents Chemother. 1995 Oct;39(10):2239-42. doi: 10.1128/AAC.39.10.2239.
5
Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.
J Antimicrob Chemother. 1993 Dec;32(6):885-91. doi: 10.1093/jac/32.6.885.
6
In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics.
Pediatr Infect Dis J. 1994 Jul;13(7):630-5. doi: 10.1097/00006454-199407000-00009.
7
Comparison of streptococci of serological group B isolated from healthy carriers and active disease in Chile.
J Med Microbiol. 1995 Mar;42(3):161-4. doi: 10.1099/00222615-42-3-161.
8
Activity of nine antimicrobial agents against Lancefield group C and group G streptococci.
Antimicrob Agents Chemother. 1982 Nov;22(5):930-2. doi: 10.1128/AAC.22.5.930.
9
Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin.
Antimicrob Agents Chemother. 1981 Aug;20(2):244-6. doi: 10.1128/AAC.20.2.244.
10
Group G Streptococci: susceptibility patterns and the effect of the inoculum size and growth phase on the bactericidal activity of penicillin.
Diagn Microbiol Infect Dis. 1988 Jan;9(1):33-40. doi: 10.1016/0732-8893(88)90058-2.
Zotero 插件